Endpoints News

2 days ago | endpts.com | Anna Brown

Roche said its $50 billion promise to expand its manufacturing footprint in the US has the potential to be “reassessed” — the same day the Swiss … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

5 days ago | endpts.com | Ngai Yeung

Virtual diabetes and chronic care startup Omada Health filed to go public on Friday, making it the second digital health company to do so this … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

5 days ago | endpts.com | Nicole DeFeudis

Iovance Biotherapeutics’ stock $IOVA dropped more than 44% on Friday afternoon, a day after the company slashed its 2025 sales predictions and reported lower-than-expected sales … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

5 days ago | endpts.com | Elizabeth Cairns

Revolution Medicines revealed new data that suggest its closely watched KRAS-targeting cancer programs could be highly competitive with similar therapies already on the market. … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

5 days ago | endpts.com | Anna Brown

Lonza said on Friday it does not expect any “material financial impact” from current and potential pharma-specific tariffs … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.